FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808946203> ?p ?o ?g. }

• W2808946203 endingPage "955" @default.
• W2808946203 startingPage "948" @default.
• W2808946203 abstract "Brain metastases (BM) from adult soft tissue or bone sarcomas are rare, and sparse data exist on their prognostic factors and management.A retrospective study was conducted in 15 centers of the French Sarcoma Group, plus one Canadian and one Swiss center, to report on clinical, histological, and treatment characteristics and to identify predictive factors of outcome.Between 1992 and 2012, 246 patients with a median age of 50 years (range: 16-86) were managed for BM. BM included 221 cerebral and cerebellar metastases and 40 cases of meningeal sarcomatosis. The most frequent histopathological subtype was leiomyosarcoma (18.7%). Histological grade was high in 118 (48%) cases. Surgery of BM was carried out for 38 (15.5%) patients. Radiotherapy and chemotherapy were administered in 168 (68.3%) and 91 (37.0%) patients, respectively. Irrespective of treatment modality, BM were controlled in 113 patients (45.9%), including 31 partial responses (12.6%) and 18 complete responses (7.3%). The median overall survival from diagnosis of brain metastasis was 2.7 months (range: 0-133). In the multivariate analysis, the following parameters influenced overall survival: chemotherapy (hazard ratio [HR] = 0.38; 95% confidence interval [CI]: 0.26-0.48), surgery (HR = 0.40; 95% CI: 0.22-0.72), stereotactic radiotherapy (HR = 0.41; 95% CI: 0.19-0.90), whole-brain radiotherapy (HR = 0.51; 95% CI: 0.35-0.76), and grade (HR = 0.65; 95% CI: 0.43-0.98).BM of sarcomas are rare and associated with a dismal outcome. Multidisciplinary management with chemotherapy, radiation therapy, and surgery is associated with a better survival.The incidence of brain and meningeal metastasis in bone and soft tissue sarcomas is estimated between 1% and 8%. Published data are derived from small retrospective case series, often in the pediatric population. A prognostic index is important to guide both clinical decision-making and outcomes research, but one such is lacking for adult sarcoma patients with brain metastases. The current study describes brain metastasis in a large cohort of sarcoma patients. This study, conducted within the French Sarcoma Group, describes the natural history of sarcoma brain metastasis and enables the proposal of strategic recommendations for subsequent clinical trials and for the management of such patients." @default.
• W2808946203 created "2018-06-29" @default.
• W2808946203 creator A5003536346 @default.
• W2808946203 creator A5004823659 @default.
• W2808946203 creator A5016485718 @default.
• W2808946203 creator A5031987093 @default.
• W2808946203 creator A5038713480 @default.
• W2808946203 creator A5044128252 @default.
• W2808946203 creator A5045172802 @default.
• W2808946203 creator A5045969321 @default.
• W2808946203 creator A5049799682 @default.
• W2808946203 creator A5050746094 @default.
• W2808946203 creator A5052242950 @default.
• W2808946203 creator A5063193415 @default.
• W2808946203 creator A5064134669 @default.
• W2808946203 creator A5065564812 @default.
• W2808946203 creator A5069761611 @default.
• W2808946203 creator A5073713547 @default.
• W2808946203 creator A5074461929 @default.
• W2808946203 creator A5076690638 @default.
• W2808946203 creator A5080620486 @default.
• W2808946203 creator A5082347575 @default.
• W2808946203 creator A5084803432 @default.
• W2808946203 date "2018-06-22" @default.
• W2808946203 modified "2023-10-15" @default.
• W2808946203 title "Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)" @default.
• W2808946203 cites W1499258626 @default.
• W2808946203 cites W1535110597 @default.
• W2808946203 cites W1964148819 @default.
• W2808946203 cites W1968720860 @default.
• W2808946203 cites W1969180882 @default.
• W2808946203 cites W1974820090 @default.
• W2808946203 cites W1988199805 @default.
• W2808946203 cites W2000345198 @default.
• W2808946203 cites W2003950027 @default.
• W2808946203 cites W2004244160 @default.
• W2808946203 cites W2013239147 @default.
• W2808946203 cites W2016901266 @default.
• W2808946203 cites W2021111991 @default.
• W2808946203 cites W2026553685 @default.
• W2808946203 cites W2033018509 @default.
• W2808946203 cites W2047856350 @default.
• W2808946203 cites W2047881870 @default.
• W2808946203 cites W2054272344 @default.
• W2808946203 cites W2054384148 @default.
• W2808946203 cites W2055706736 @default.
• W2808946203 cites W2058961654 @default.
• W2808946203 cites W2062352315 @default.
• W2808946203 cites W2064972959 @default.
• W2808946203 cites W2065438292 @default.
• W2808946203 cites W2071542599 @default.
• W2808946203 cites W2075718758 @default.
• W2808946203 cites W2078845052 @default.
• W2808946203 cites W2082232106 @default.
• W2808946203 cites W2087896886 @default.
• W2808946203 cites W2099297861 @default.
• W2808946203 cites W2103517531 @default.
• W2808946203 cites W2116652221 @default.
• W2808946203 cites W2125062979 @default.
• W2808946203 cites W2133578604 @default.
• W2808946203 cites W2162065895 @default.
• W2808946203 cites W2162887147 @default.
• W2808946203 cites W2163258576 @default.
• W2808946203 cites W2166738660 @default.
• W2808946203 cites W2906992685 @default.
• W2808946203 doi "https://doi.org/10.1634/theoncologist.2017-0136" @default.
• W2808946203 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6156185" @default.
• W2808946203 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29934413" @default.
• W2808946203 hasPublicationYear "2018" @default.
• W2808946203 type Work @default.
• W2808946203 sameAs 2808946203 @default.
• W2808946203 citedByCount "14" @default.
• W2808946203 countsByYear W28089462032020 @default.
• W2808946203 countsByYear W28089462032021 @default.
• W2808946203 countsByYear W28089462032022 @default.
• W2808946203 countsByYear W28089462032023 @default.
• W2808946203 crossrefType "journal-article" @default.
• W2808946203 hasAuthorship W2808946203A5003536346 @default.
• W2808946203 hasAuthorship W2808946203A5004823659 @default.
• W2808946203 hasAuthorship W2808946203A5016485718 @default.
• W2808946203 hasAuthorship W2808946203A5031987093 @default.
• W2808946203 hasAuthorship W2808946203A5038713480 @default.
• W2808946203 hasAuthorship W2808946203A5044128252 @default.
• W2808946203 hasAuthorship W2808946203A5045172802 @default.
• W2808946203 hasAuthorship W2808946203A5045969321 @default.
• W2808946203 hasAuthorship W2808946203A5049799682 @default.
• W2808946203 hasAuthorship W2808946203A5050746094 @default.
• W2808946203 hasAuthorship W2808946203A5052242950 @default.
• W2808946203 hasAuthorship W2808946203A5063193415 @default.
• W2808946203 hasAuthorship W2808946203A5064134669 @default.
• W2808946203 hasAuthorship W2808946203A5065564812 @default.
• W2808946203 hasAuthorship W2808946203A5069761611 @default.
• W2808946203 hasAuthorship W2808946203A5073713547 @default.
• W2808946203 hasAuthorship W2808946203A5074461929 @default.
• W2808946203 hasAuthorship W2808946203A5076690638 @default.
• W2808946203 hasAuthorship W2808946203A5080620486 @default.
• W2808946203 hasAuthorship W2808946203A5082347575 @default.
• W2808946203 hasAuthorship W2808946203A5084803432 @default.

• next